Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

NCT01764451 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT01764451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Lead sponsor
University of New Mexico
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2012
Completion date
January 31, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cavernous angioma, familial, cerebral cavernous hemangioma, cerebral cavernous malformations